Literature DB >> 8406857

Local immunity in lung-associated lymph nodes in a murine model of pulmonary histoplasmosis.

M F Fojtasek1, M R Sherman, T Garringer, R Blair, L J Wheat, C T Schnizlein-Bick.   

Abstract

Local immunity against acute pulmonary histoplasmosis was studied in the lung-associated lymph nodes of normal nonimmune mice infected intratracheally with live Histoplasma capsulatum yeasts. The phenotypes and distribution of cells in lung-associated lymph nodes and spleens were determined by flow cytometry. In addition, the immune responsiveness of these cells was evaluated by in vitro blastogenesis. Anti-H. capsulatum antibodies in serum and H. capsulatum antigen in tissue were measured by immunoassays. Cellular immune responses were greater in the lymph nodes than in the spleens. In lymph nodes 7 days after infection, a marked increase in the number of B lymphocytes caused the percentage to rise to 43%, compared with 26% in controls, and it remained elevated throughout the course of infection. A CD3+ cell that did not express CD4 or CD8 increased in number until it constituted 21% of lymph node cells, compared with 5% in controls, by day 14. The numbers of CD4+ and CD8+ T lymphocytes were modestly increased from days 7 to 35, but their percentages dropped because of the greater numbers of B lymphocytes and CD3+4-8- cells. Macrophages consistently constituted 2 to 3% of lymph node cells during the study. In spleens 7 days after infection, the percentage of macrophages in infected mice rose to 21%, compared with 9% in controls, but the total spleen cell number did not increase until day 14, when all cell subsets were nearly double in number. The in vitro blastogenic response of lymph node cells to H. capsulatum peaked at day 7, but spleen cell response was minimal during the course of infection. Histoplasma-specific serum immunoglobulin G antibodies reached peak levels by day 21 and remained high to the end of the study. In contrast, levels of antigen-specific immunoglobulin M antibodies were very low. These data suggest that antigen-specific immune responses occur in lung-associated lymph nodes and that this draining lymph node response may be an important component in host defense against Histoplasma lung infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406857      PMCID: PMC281211          DOI: 10.1128/iai.61.11.4607-4614.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  B cell response to T helper cell subsets. II. Both the stage of T cell differentiation and the cytokines secreted determine the extent and nature of helper activity.

Authors:  M Croft; S L Swain
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

Review 2.  Cognate interactions between helper T cells and B cells.

Authors:  R J Noelle; E C Snow
Journal:  Immunol Today       Date:  1990-10

3.  Novel abnormality in subpopulations of circulating lymphocytes. T gamma delta and CD2-, 3+, 4-, 8- lymphocytes in histoplasmosis-associated immunodeficiency.

Authors:  P F Lehmann; T Sawyer; H Donabedian
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

4.  Two forms of the T-cell receptor gamma protein found on peripheral blood cytotoxic T lymphocytes.

Authors:  M B Brenner; J McLean; H Scheft; J Riberdy; S L Ang; J G Seidman; P Devlin; M S Krangel
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

5.  Morphogenesis and pathogenicity of Histoplasma capsulatum.

Authors:  G Medoff; G S Kobayashi; A Painter; S Travis
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

6.  Experimental histoplasmosis in the mouse. Immunoglobulin class response, total immunoglobulin A levels, immune complex formation, and occurrence of antigen in serum and urine.

Authors:  G H Sweet; S M Dulohery
Journal:  Am Rev Respir Dis       Date:  1989-10

7.  NK1.1+ thymocytes. Adult murine CD4-, CD8- thymocytes contain an NK1.1+, CD3+, CD5hi, CD44hi, TCR-V beta 8+ subset.

Authors:  Z K Ballas; W Rasmussen
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

8.  Correlation of Histoplasma capsulatum polysaccharide antigen with the severity of infection in murine histoplasmosis.

Authors:  B J Williams; P Connolly-Stringfield; M Bartlett; M Durkin; T Garringer; R Blair; K Connolly; R P Tewari; L J Wheat
Journal:  J Clin Lab Anal       Date:  1991       Impact factor: 2.352

9.  Immunohistopathology of murine pulmonary histoplasmosis during normal and hypersensitive conditions.

Authors:  J Defaveri; J R Graybill
Journal:  Am Rev Respir Dis       Date:  1991-12

10.  Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes.

Authors:  J A Bluestone; R Q Cron; M Cotterman; B A Houlden; L A Matis
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  8 in total

1.  Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.

Authors:  P Connolly; L J Wheat; C Schnizlein-Bick; M Durkin; S Kohler; M Smedema; J Goldberg; E Brizendine; D Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Comparison of nikkomycin Z with amphotericin B and itraconazole for treatment of histoplasmosis in a murine model.

Authors:  J Goldberg; P Connolly; C Schnizlein-Bick; M Durkin; S Kohler; M Smedema; E Brizendine; R Hector; J Wheat
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Evolution of the primary immune response to Histoplasma capsulatum in murine lung.

Authors:  J A Cain; G S Deepe
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

Authors:  P Connolly; J Wheat; C Schnizlein-Bick; M Durkin; S Kohler; M Smedema; J Goldberg; E Brizendine; D Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

5.  Antibody therapy for histoplasmosis.

Authors:  Joshua D Nosanchuk; Rosely M Zancopé-Oliveira; Andrew J Hamilton; Allan J Guimarães
Journal:  Front Microbiol       Date:  2012-02-02       Impact factor: 5.640

Review 6.  Hepatic Histoplasmosis: An Update.

Authors:  Maimuna Sayeed; Md Benzamin; Luthfun Nahar; Masud Rana; Aisharza Sultana Aishy
Journal:  J Clin Transl Hepatol       Date:  2021-09-22

7.  Histoplasmosis presenting as granulomatous hepatitis: case report and review of the literature.

Authors:  Nancy A Rihana; Manasa Kandula; Ana Velez; Kumud Dahal; Edward B O'Neill
Journal:  Case Rep Med       Date:  2014-06-09

Review 8.  The regulation of pulmonary immunity.

Authors:  M F Lipscomb; D E Bice; C R Lyons; M R Schuyler; D Wilkes
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.